DIRECT‐ACTING ANTIVIRALS DURING OR AFTER IMMUNO‐CHEMOTHERAPY IN HEPATITIS C VIRUS‐ASSOCIATED DIFFUSE LARGE B‐CELL LYMPHOMAS. (June 2017) - Merli, M.; Alric, L.; Mannelli, L.; De Angelis, F.; Ferrari, A.; Capecchi, M.; Pirisi, M.; Visco, C.; Piazza, F.; Loustaud‐Ratti, V.; Goldaniga, M.; Zancanella, M.; et al.